• SPX
  • $5,893.62
  • 0.39 %
  • $23.00
  • DJI
  • $43,389.60
  • -0.13 %
  • -$55.39
  • N225
  • $38,511.21
  • 0.76 %
  • $290.58
  • FTSE
  • $8,109.32
  • 0.57 %
  • $45.71
  • IXIC
  • $18,791.81
  • 0.6 %
  • $111.69
App Store Download on the App Store Google Play GET IT ON Google Play

Get The App

App Store Download on the App Store Google Play GET IT ON Google Play
CG Oncology, Inc. Common stock (CGON) Stock Price, News & Analysis

CG Oncology, Inc. Common stock (CGON) Stock Price, News & Analysis

Currency in USD Disclaimer

$33.21

$0.32

(0.96%)

Day's range
$32.55
Day's range
$34.11
50-day range
$32.53
Day's range
$40.47
  • Country: N/A
  • ISIN: N/A
52 wk range
$25.77
Day's range
$50.23
  • CEO: Mr. Arthur Kuan
  • Website: N/A


We are preparing, please wait

1 Hour 1 Day 1 Week 1 Year Advanced Chart
Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 84.44
  • Piotroski Score 2.00
  • Grade Buy
  • Symbol (CGON)
  • Company CG Oncology, Inc. Common stock
  • Price $33.21
  • Changes Percentage (0.96%)
  • Change $0.32
  • Day Low $32.55
  • Day High $34.11
  • Year High $50.23

CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. Their product candidate cretostimogene, is initially in clinical development for the treatment of patients with high-risk Non-Muscle Invasive Bladder Cancer who are unresponsive to Bacillus Calmette Guerin (BCG) therapy, the current standard-of-care for high-risk NMIBC.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 11/14/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $60.00
  • High Stock Price Target $75.00
  • Low Stock Price Target $52.00
  • Potential Upside/Downside N/A
  • Consensus Rating Strong Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $0.00
  • Trailing P/E Ratio N/A
  • Forward P/E Ratio N/A
  • P/E Growth N/A
  • Net Income $-48,607,000

Income Statement

Quarterly

Annual

Latest News of CGON

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

View ALL
Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

CG Oncology, Inc. Common stock Frequently Asked Questions

  • What were the earnings of CGON in the last quarter?

    In the last quarter CG Oncology, Inc. Common stock earnings were on Thursday, August, 8th. The CG Oncology, Inc. Common stock maker reported -$0.28 EPS for the quarter, beating analysts' consensus estimates of -$0.42 by $0.14.

  • What is the CG Oncology, Inc. Common stock stock price today?

    Today's price of CG Oncology, Inc. Common stock is $33.21 — it has increased by +0.96% in the past 24 hours. Watch CG Oncology, Inc. Common stock stock price performance more closely on the chart.

  • Does CG Oncology, Inc. Common stock release reports?

    Yes, you can track CG Oncology, Inc. Common stock's financials in yearly and quarterly reports directly on Stocks.News.

  • What is the CG Oncology, Inc. Common stock stock forecast?

    Watch the CG Oncology, Inc. Common stock chart and read a more detailed CG Oncology, Inc. Common stock stock forecast to see what analysts suggest you do with its shares.

  • What is CG Oncology, Inc. Common stock stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by CG Oncology, Inc. Common stock stock ticker.

  • How to buy CG Oncology, Inc. Common stock stocks?

    Like other stocks, CGON shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is CG Oncology, Inc. Common stock's EBITDA?

    CG Oncology, Inc. Common stock measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in CG Oncology, Inc. Common stock’s financial statements.

  • What is the CG Oncology, Inc. Common stock's net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -238.2696078431, which equates to approximately -23,826.96%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in CG Oncology, Inc. Common stock stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including CG Oncology, Inc. Common stock's financials relevant news, and technical analysis. CG Oncology, Inc. Common stock's technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for CG Oncology, Inc. Common stock stock currently indicates a “sell” signal. For more insights, review CG Oncology, Inc. Common stock’s technical analysis.

  • A revenue figure for CG Oncology, Inc. Common stock for its last quarter?

    CG Oncology, Inc. Common stock published it's last quarterly revenues at $43,000.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In

or
download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Sign Up With Email Address
or
google app download Continue with Google ios app download Continue with Apple

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.